Q: What is Crizotinib?

Crizotinib belongs to a class of medications known as kinase inhibitors . It works by blocking the action of certain abnormal proteins that signal cancer cells to multiply and spread throughout the body. By interfering with these signals, the medication helps to slow or stop the growth of cancer cells.

Q: What is Crizotinib used for?

Crizotinib is used to treat: Anaplastic lymphoma kinase-positive non-small cell lung cancer ROS1-positive non-small cell lung cancer

Q: How does Crizotinib work?

Mechanism of Action Crizotinib belongs to a class of medications called kinase inhibitors. It is designed to target and block the activity of specific proteins found on the surface or inside of cancer cells. These proteins include anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1), and hepatocyte growth factor receptor (HGFR). In some types of cancer, such as certain forms of non-small cell lung cancer, the genes responsible for these proteins become abnormal or fused with other genes. This genetic change causes the proteins to be constantly active, sending continuous signals that tell the cancer cells to grow, multiply, and spread throughout the body. How It Affects Cancer Cells Crizotinib works by binding to these overactive proteins and blocking their signaling pathways. When these signals are interrupted, the following may occur: The growth and division of cancer cells are slowed or stopped. The tumor may shrink in size. The spread of the cancer to other parts of the body may be delayed. Because crizotinib specifically targets these abnormal proteins, it is considered a targeted therapy. It is typically used only in patients whose tumors have been tested and confirmed to have specific genetic markers, such as an ALK-positive or ROS1-positive status.

Q: What are the brand names for Crizotinib?

Crizotinib is sold under the brand name Xalkori .

Q: What are the active ingredients in Crizotinib?

The active ingredient in Crizotinib is crizotinib .

Q: What are the side effects of Crizotinib?

Common side effects of Crizotinib may include: vision disorders nausea diarrhea and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Crizotinib?

Crizotinib belongs to the ALK and ROS1 tyrosine kinase inhibitor drug class.

Q: What is the dosage of Crizotinib and how do I take it?

How to Take Crizotinib is taken by mouth, usually twice a day. It can be taken with or without food. It is important to take the medication at approximately the same times every day to maintain a steady level of the drug in your body. Administration Instructions Swallow capsules whole. Do not crush, chew, dissolve, or open the capsules. If you are using the pellet form, follow the specific instructions provided by your healthcare professional regarding how to swallow them or mix them with food. Avoid eating grapefruit or drinking grapefruit juice while being treated with crizotinib, as it may interfere with how the medication is processed by your body. Missed Dose If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose (typically within 6 hours), skip the missed dose and take the next one at your regular time. Do not take two doses at once to make up for a missed one. Vomiting After a Dose If you vomit after taking a dose of crizotinib, do not take an additional dose. Simply wait and take your next scheduled dose at the usual time.

Q: Is Crizotinib safe during pregnancy and breastfeeding?

Pregnancy Crizotinib may cause fetal harm when administered to a pregnant woman. Based on its mechanism of action and findings from animal studies, this medication can lead to birth defects or the loss of a pregnancy. It is important to discuss pregnancy status and family planning with a healthcare provider before starting this medication. The following precautions are generally advised: Pregnancy Testing: Females who are able to become pregnant should have a pregnancy test to confirm they are not pregnant before beginning treatment. Contraception for Females: Effective birth control should be used during treatment and for at least 4 months after the last dose. Contraception for Males: Men with female partners of reproductive potential should use effective contraception (such as condoms) during treatment and for at least 90 days after the last dose. Breastfeeding There is no information on the presence of crizotinib in human milk or its effects on a breastfed child. Because of the potential for serious adverse reactions in nursing infants, breastfeeding is not recommended during treatment and for 45 days after the final dose.

Question 1

What is Crizotinib?

Accepted Answer

Crizotinib belongs to a class of medications known as kinase inhibitors. It works by blocking the action of certain abnormal proteins that signal cancer cells to multiply and spread throughout the body.

By interfering with these signals, the medication helps to slow or stop the growth of cancer cells.

Question 2

What is Crizotinib used for?

Accepted Answer

Crizotinib is used to treat:

Anaplastic lymphoma kinase-positive non-small cell lung cancer
ROS1-positive non-small cell lung cancer

Question 3

How does Crizotinib work?

Accepted Answer

Mechanism of Action

Crizotinib belongs to a class of medications called kinase inhibitors. It is designed to target and block the activity of specific proteins found on the surface or inside of cancer cells. These proteins include anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1), and hepatocyte growth factor receptor (HGFR).

In some types of cancer, such as certain forms of non-small cell lung cancer, the genes responsible for these proteins become abnormal or fused with other genes. This genetic change causes the proteins to be constantly active, sending continuous signals that tell the cancer cells to grow, multiply, and spread throughout the body.

How It Affects Cancer Cells

Crizotinib works by binding to these overactive proteins and blocking their signaling pathways. When these signals are interrupted, the following may occur:

The growth and division of cancer cells are slowed or stopped.
The tumor may shrink in size.
The spread of the cancer to other parts of the body may be delayed.

Because crizotinib specifically targets these abnormal proteins, it is considered a targeted therapy. It is typically used only in patients whose tumors have been tested and confirmed to have specific genetic markers, such as an ALK-positive or ROS1-positive status.

Question 4

What are the brand names for Crizotinib?

Accepted Answer

Crizotinib is sold under the brand name Xalkori.

Question 5

What are the active ingredients in Crizotinib?

Accepted Answer

The active ingredient in Crizotinib is crizotinib.

Question 6

What are the side effects of Crizotinib?

Accepted Answer

Common side effects of Crizotinib may include:

vision disorders
nausea
diarrhea
and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Crizotinib?

Accepted Answer

Crizotinib belongs to the ALK and ROS1 tyrosine kinase inhibitor drug class.

Question 8

What is the dosage of Crizotinib and how do I take it?

Accepted Answer

How to Take

Crizotinib is taken by mouth, usually twice a day. It can be taken with or without food. It is important to take the medication at approximately the same times every day to maintain a steady level of the drug in your body.

Administration Instructions

Swallow capsules whole. Do not crush, chew, dissolve, or open the capsules.
If you are using the pellet form, follow the specific instructions provided by your healthcare professional regarding how to swallow them or mix them with food.
Avoid eating grapefruit or drinking grapefruit juice while being treated with crizotinib, as it may interfere with how the medication is processed by your body.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose (typically within 6 hours), skip the missed dose and take the next one at your regular time. Do not take two doses at once to make up for a missed one.

Vomiting After a Dose

If you vomit after taking a dose of crizotinib, do not take an additional dose. Simply wait and take your next scheduled dose at the usual time.

Question 9

Is Crizotinib safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Crizotinib may cause fetal harm when administered to a pregnant woman. Based on its mechanism of action and findings from animal studies, this medication can lead to birth defects or the loss of a pregnancy. It is important to discuss pregnancy status and family planning with a healthcare provider before starting this medication.

The following precautions are generally advised:

Pregnancy Testing: Females who are able to become pregnant should have a pregnancy test to confirm they are not pregnant before beginning treatment.
Contraception for Females: Effective birth control should be used during treatment and for at least 4 months after the last dose.
Contraception for Males: Men with female partners of reproductive potential should use effective contraception (such as condoms) during treatment and for at least 90 days after the last dose.

Breastfeeding

There is no information on the presence of crizotinib in human milk or its effects on a breastfed child. Because of the potential for serious adverse reactions in nursing infants, breastfeeding is not recommended during treatment and for 45 days after the final dose.

Question 10

What forms and strengths does Crizotinib come in?

Accepted Answer

Crizotinib is available in the following oral formulations:

Capsules: These are hard-shell capsules intended to be swallowed whole. They should not be crushed, dissolved, or opened before administration.
Oral Pellets: These consist of small pellets contained within a shell. The shell is designed to be opened so the pellets can be administered, which may be helpful for patients who have difficulty swallowing whole capsules.

Question 11

What is the FDA approval status of Crizotinib?

Accepted Answer

FDA-Approved Indications

The U.S. Food and Drug Administration (FDA) has approved crizotinib for the treatment of several specific cancers:

Non-Small Cell Lung Cancer (NSCLC): It is approved for adults with metastatic NSCLC whose tumors are positive for the anaplastic lymphoma kinase (ALK) or ROS1 gene alterations.
Anaplastic Large Cell Lymphoma (ALCL): It is approved for pediatric patients (1 year of age and older) and young adults with systemic ALCL that is ALK-positive and has either returned or did not respond to previous treatments.
Inflammatory Myofibroblastic Tumor (IMT): It is approved for adult and pediatric patients (1 year of age and older) with ALK-positive IMT that cannot be removed by surgery, has returned, or did not respond to other therapies.

Diagnostic Testing Requirements

FDA approval for these uses is contingent upon the presence of specific biomarkers. Patients must have their ALK or ROS1 status confirmed by an FDA-approved diagnostic test before starting treatment to ensure the medication is appropriate for their specific cancer type.

Safety and Regulatory Oversight

Crizotinib is not currently subject to any FDA Boxed Warnings or Risk Evaluation and Mitigation Strategy (REMS) programs. The FDA continues to monitor the safety and effectiveness of the drug through post-marketing surveillance and clinical data reviews.

Question 12

What should I know about Crizotinib and cost?

Accepted Answer

Insurance and Out-of-Pocket Costs

Crizotinib is a high-cost specialty medication, and the final price for a patient is largely determined by their health insurance plan. Most insurance providers, including Medicare and private plans, cover the medication, but it is often placed in a high-cost specialty tier. This means patients may be responsible for a significant copayment or coinsurance amount. Some plans may also require prior authorization before the medication can be dispensed.

Specialty Pharmacy Services

Crizotinib is usually available only through specialty pharmacies rather than standard retail pharmacies. These pharmacies are equipped to handle high-cost medications and can often assist patients with the insurance approval process and coordinate delivery of the drug.

Financial Assistance Programs

Because of the high cost of treatment, several resources may be available to help reduce the financial burden:

Manufacturer Assistance: Programs may be available to provide the medication at a lower cost or for free to patients who meet certain financial criteria or lack insurance.
Copay Cards: Patients with commercial insurance may qualify for copay cards that reduce their monthly out-of-pocket expenses.
Non-profit Organizations: Various charitable foundations offer grants to help patients cover the costs of cancer medications and related expenses.

Patients are encouraged to speak with their healthcare provider, pharmacist, or insurance company to understand the specific costs and assistance options available to them.

Crizotinib

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Crizotinib

Hospitals.net Disclosure